IDIBAPS and EUROIMMUN sign a new agreement on research into neuronal inflammatory diseases
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1
Aleix Prat is leading the research, which focuses on discovering new ways of diagnosing hormone receptor-positive breast cancer, as well as new thera1
Understanding the mechanisms involved in ulcerative colitis and Crohn disease and identifying new therapeutic targets and markers for response to tre1
Researchers from Hospital Clínic-IDIBAPS have participated in an international collaboration led by IBEC in which they have generated human mini-kidn1
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioratio1
Castaño, a researcher in the IDIBAPS group Pathogenesis and Prevention of Diabetes and CIBERDEM, has been recognized for his junior basic research in1
The publication collects the latest advances in neurology since 2002 and in the commemoration of its twentieth anniversary highlights the guidelines1
Both diseases have clinical manifestations that may be similar, but a study, in which IDIBAPS researchers have participated, has identified markers t1
The report, published in the journal Brain, describes the challenges in transforming and applying research advances in this regenerative therapy into1
The analysis of two cohorts from the United Kingdom and Catalonia concluded that at least one dose of vaccine does not increase the risk of suffering1